The US pneumococcal testing market is expanding due to the increasing demand for rapid and accurate infectious disease diagnostics. The rising prevalence of respiratory infections, advanced healthcare infrastructure, and growing adoption of molecular diagnostic technologies are supporting market growth. Healthcare providers are focusing on improved testing solutions to enable early detection...